Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
about
Advances in the treatment of invasive neonatal candidiasisPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsGuidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerEfficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of thePopulation pharmacokinetics of amphotericin B lipid complex in neonates.Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.Antifungal agents for the treatment of systemic fungal infections in children.Management of neonatal candidiasis. Neonatal Candidiasis Study GroupAmphotericin B lipid complex for the treatment of invasive fungal infections.Antifungal chemotherapeutics.Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis.Clinical pharmacology of antifungal agents in pediatric patients.Diagnosis and treatment of aspergillosis in children.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.Invasive aspergillosis in children with acquired immunodeficiencies.Invasive fungal infections in newborns and current management strategies.Clinical pharmacology of antifungal agents to overcome drug resistance in pediatric patients.Diagnostic Imaging and Invasive Fungal Diseases in Children.Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.Amphotericin B: time for a new "gold standard".Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children.Pediatric Invasive Aspergillosis.Les antifongiques pour le traitement des infections fongiques systémiques chez les enfants.
P2860
Q27022585-E5AF004A-028A-4A50-8F23-88D1DBBCFD7FQ27025299-ED4CF8BF-5868-43A0-8AEA-AF5372819A09Q33650105-BA15D848-37E8-47BD-91A6-2A8E2B00902DQ33978902-E23E3E2D-A5E4-4488-8D34-25BBCE5F8DF3Q34212799-B0F4EDB2-EAFD-4849-AA47-88391C4E564AQ34228332-8BD5CB4F-1EB7-48C5-A8BC-9F56EE38EE28Q34382518-AD13D2F0-88CA-4BAA-B7D0-BA580A7F565CQ34437094-0A625004-A5A2-4319-9224-C4385ADD0EDCQ34680771-C22D0360-E35D-45C4-8A50-4F05770549B2Q35575017-B3AD53AF-882B-47F7-AEE9-EC897354C2E5Q36111677-ECF662B3-7158-494F-A8E9-EC6378453B28Q36489697-79548454-4081-468A-BB3E-3B3B8F1D3B1AQ36968140-1D3FFC43-831C-4EDF-A1AF-CC78B20133BFQ37463228-5AB609EA-9851-431E-B810-89741190AFF5Q37889382-9136E2EE-1583-4FC0-9626-3D5D9FA1FAB3Q37925817-8236A5E7-3922-402E-905B-E0BD14DA5AC4Q37954958-EF8EB8AA-AA9D-4171-A169-889ACF99250EQ38119554-E2236ECE-C668-4650-AE13-65120F39E87FQ38314467-C7B482C3-BC22-498A-9E62-4265661D529CQ41996451-65D3DEAE-6AF2-46EE-AC20-9334882059EEQ43636264-822AE133-5215-4E2B-8350-12B992C1F47EQ44527998-99F63066-4EF4-45A0-97CF-B7321B81F2A0Q49182676-081134DF-CC4D-4947-A86C-3367D5308388Q49612998-F0CC4103-8683-4787-ADA6-E3FFF11E14EDQ55461573-B0D4F179-F5FE-4124-8E0D-CDF2EB3FB87E
P2860
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@en
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@nl
type
label
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@en
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@nl
prefLabel
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@en
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@nl
P2093
P1476
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
@en
P2093
Chanock SJ
Dinubile MJ
P304
P356
10.1097/00006454-199908000-00010
P577
1999-08-01T00:00:00Z